Evidence map›Paper›PMID 42523104›Full record

ArticleMicrobiology spectrum2026

Protection against

Kai Wengelnik, Rakhee Lohia, Anais Paveyranne, Jordy Le Guet, Gregor P Jose, Stéphane Azoulay, Eric Honoré, Dominique Douguet

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kai Wengelnik *LPHI, University of Montpellier, CNRS, Inserm, Montpellier, France.ORCID 0000-0002-4547-4205
Rakhee Lohia *LPHI, University of Montpellier, CNRS, Inserm, Montpellier, France.ORCID 0000-0001-5041-3776
Anais PaveyranneUniversity Côte d'Azur, ICN, CNRS, Nice, France.
Jordy Le GuetLPHI, University of Montpellier, CNRS, Inserm, Montpellier, France.
Gregor P JoseUniversity Côte d'Azur, IPMC, CNRS, Inserm U1323, UMR7275, Labex ICST, Valbonne, France.ORCID 0000-0001-6303-2286
Stéphane AzoulayUniversity Côte d'Azur, ICN, CNRS, Nice, France.ORCID 0000-0002-1125-9291
Eric HonoréUniversity Côte d'Azur, IPMC, CNRS, Inserm U1323, UMR7275, Labex ICST, Valbonne, France.ORCID 0000-0002-8007-0919
Dominique DouguetUniversity Côte d'Azur, IPMC, CNRS, Inserm U1323, UMR7275, Labex ICST, Valbonne, France.ORCID 0000-0001-6209-6464

Funding

Agence Nationale de la Recherche (ANR) ANR-16-IDEX-0006Agence Nationale de la Recherche (ANR) ANR-17-CE13-0012-02Agence Nationale de la Recherche (ANR) ANR-19-CE14-0029-01Agence Nationale de la Recherche (ANR) ANR-20-CE14-0032-01Centre National de la Recherche Scientifique (CNRS) PREMAT317Fondation pour la Recherche Médicale (FRM)
6 · The paper itself

Abstract

IMPORTANCE:

Indexed as

BabesiaBabesiosisErythrocytesIon ChannelsAnimalsCattleHumansPlasmodium falciparumPyrazinesThiadiazolesIon ChannelsPIEZO1 protein, humanPyrazinesThiadiazolesyoda-1Babesia divergensbabesiosiserythrocytemechanosensitive ion channelPiezo1

Identifiers

PMID42523104
PMCPMC13532334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.